Entry Detail



General Information

Database ID:exR0763151
RNA Name:RPL4
RNA Type:mRNA
Chromosome:chr15
Starnd:-
Coordinate:
Start Site(bp):66498015End Site(bp):66524532
External Links:ENSG00000174444



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AIF1L
chr9
131096476
131123152
+
ADD1
chr4
2843857
2930076
+
AL049629.2
chr11
33698261
33722467
-
AL133352.1
chr10
100505628
100529881
-
AASDHPPT
chr11
106075501
106098699
+
AC004223.3
chr17
35011349
35121493
-
ABT1
chr6
26596953
26600739
+
ADSL
chr22
40346500
40390463
+
AC245033.1
chr15
82536788
82573194
-
AC013394.1
chr15
92883413
92949230
+
AC008982.1
chr19
38817471
38840178
-
AC003002.3
chr19
57389884
57419994
+
ACTN4
chr19
38647649
38731589
+
ADD2
chr2
70607618
70768225
-
ADGRL2
chr1
81306160
81992436
+
AC004922.1
chr7
99325879
99394653
+
AC120057.2
chr17
7240427
7244635
-
ALAD
chr9
113386312
113401290
-
ACTC1
chr15
34790230
34795549
-
ADAR
chr1
154582057
154628013
-
AIMP1
chr4
106315544
106349456
+
ADCY3
chr2
24819169
24919839
-
AC015813.2
chr17
57989038
58007246
-
ABRACL
chr6
139028745
139043302
+
AD000671.2
chr19
35739252
35745432
-
ACP5
chr19
11574660
11579008
-
AGBL5
chr2
27042364
27070622
+
ABCC4
chr13
95019835
95301475
-
AC007192.1
chr19
18153158
18178117
+
AGAP2
chr12
57723761
57742157
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4745-5p
chr19
804941
804963
+
hsa-miR-6889-5p
chr22
41253023
41253045
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005899.4
chr17
32328441
32329395
+
AC007952.4
chr17
19112000
19112636
-
AC016026.1
chr22
17787652
17811497
-
AC016876.2
chr17
7581964
7584086
-
AC026362.1
chr12
122975320
122982907
+
AC051619.7
chr15
45200325
45200632
-
AC126365.1
chr17
20788071
20789584
+
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.